Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today presented a poster on Part 1, the open-label portion, of the study of SLS-002 at the IASRAFSP International Summit on Suicide Research Virtual Conference. The poster titled A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 .
/PRNewswire/ Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the medical cost of.
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 14, 2021 /PRNewswire/ Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per
- FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 5, 2021 /PRNewswire/ The psychedelic drugs market is creating major potential for treatment of mental illnesses, and
/PRNewswire/ The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to see more demand.